Evidence map›Paper›PMID 40715434›Full record

ArticleScientific reports2025

Drug related problems and associated factors among thyroid disorder patients in Northwest Ethiopia.

Fisseha Nigussie Dagnew, Samuel Agegnew Wondm, Melak Erara Mengistu, Samuel Berihun Dagnew, Tilaye Arega Moges, Gashaw Binega Mekonnen

Abstract readMulticenter Study
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Fisseha Nigussie DagnewDepartment of Clinical Pharmacy, Pharmacy Education and Clinical Services Directorate, College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia. fissehanigussie1921@gmail.com.
Samuel Agegnew WondmDepartment of Pharmacy, College of Health Sciences, Debre Markos University, Debre Markos, Ethiopia.
Melak Erara MengistuDepartment of Clinical Pharmacy, School of Pharmacy, College of Medicine and Health Science, University of Gondar, Gondar, Ethiopia.
Samuel Berihun DagnewDepartment of Clinical Pharmacy, Pharmacy Education and Clinical Services Directorate, College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia.
Tilaye Arega MogesDepartment of Clinical Pharmacy, Pharmacy Education and Clinical Services Directorate, College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia.
Gashaw Binega MekonnenDepartment of Clinical Pharmacy, School of Pharmacy, College of Medicine and Health Science, University of Gondar, Gondar, Ethiopia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thyroid disorder patients are likely to have a prescription for various categories of drugs including those with a narrow therapeutic index and others, which affects thyroid function. However, information regarding drug therapy problems in thyroid patients has not been studied here yet. Thus this study aimed to assess drug therapy problems and associated factors among thyroid disorder patients, who had follow-ups at Northwest Hospitals of Ethiopia. A multicenter hospital-based cross-sectional study design was employed through patient interviews and chart review at public hospitals in Northwest Ethiopia. A simple random sampling technique was used to recruit patients for interviews. The identified drug-related problem was recorded and classified using Cipolle et al. 2012, adverse drug reactions were assessed by using the Naranjo algorithm of adverse drug reaction probability scale, and Up-to-date was used for the drug-drug interaction checker. The collected data was cleared, entered into epidata, checked for correctness, and exported to STATA version 17 for analysis. The results were summarized using descriptive statistics including frequency, mean, median, and standard deviation. Logistic regression analysis was conducted to identify the independent predictors of drug therapy problems. A P-value < 0.05 is considered statistically significant. Among 351 study participants most of them 300 (85.47%) were females. The study participants' mean (± SD) age was 45.1± (0.74) years. At least one drug-related problem was recorded from 60.11%, (95% CI: 54.9-65.13) of study participants with a mean of 1.54 ± 0.046 drug-related problems per patient. The most common drug-related problems were non-adherence (34.47%) followed by adverse drug reactions (17.2%) and ineffective drug therapy (8.2%). Factors independently associated with drug-related problems were age [AOR = 2.85, 95%CI: (1.05-7.69), P-value = 0.039], poly-pharmacy [AOR = 2.57, 95%CI: (1.01-6.29), P-value = 0.046], comorbidity [AOR = 2.09, 95%CI: (1.07-4.05), P-value = 0.030], and purchasing medication from private pharmacy [AOR = 2.62, 95%CI: (1.06-6.49), P-value = 0.038]. The prevalence of drug-related problems among adult thyroid disease patients who had follow up at ambulatory clinics was very high. Age, poly-pharmacy, comorbidity, and purchasing medication in private pharmacies were independent predictors of drug-related problems. The most commonly involved medication class in experiencing drug-related problems was thionamides.

Indexed as

Drug-Related Side Effects and Adverse ReactionsThyroid DiseasesAdolescentAdultAgedCross-Sectional StudiesDrug InteractionsEthiopiaFemaleHumansMaleMiddle AgedRisk FactorsYoung AdultDrug-related problemsEthiopiaPatient safetyRisk factorsThyroid disorders

Identifiers

PMID40715434
PMCPMC12297595

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.